Cancer Archive — Page 15 of 67
-
August 8, 2023
Chronic complications from immunotherapies more prevalent and persistent than previously shown among melanoma survivors
A Vanderbilt study has found that chronic immunotherapy-related complications are more prevalent and persistent than previously shown among melanoma survivors. -
August 3, 2023
Study finds hallmarks of T cell exhaustion within hours of tumor exposure
Vanderbilt researchers found that T cells become “exhausted” within hours of encountering a tumor, challenging existing ideas about how T cells become dysfunctional. -
July 25, 2023
Signaling pathways in liposarcomas
A broad bioinformatics approach revealed that Hedgehog signaling is upregulated in dedifferentiated liposarcoma, suggesting this pathway may be an early indicator of poor prognosis and a potential therapeutic target. -
July 20, 2023
Stem cell recipient meets donor who saved her life 10 years ago
Each passing day is precious for Deneen Eastridge, but a decade is a priceless gift. The Dallas resident came to Nashville recently to meet Trina Hughes, the stem cell donor who gave her the gift of life 10 years ago. -
July 7, 2023
Study reveals new clue to gastric cancer
Researchers at Vanderbilt University Medical Center have uncovered evidence of fibroblast cells' direct involvement in the development of gastric cancer. -
June 29, 2023
Selenium signal found in colorectal cancer: study
An antioxidant transporter of the trace mineral selenium that protects against inflammatory bowel disease has the opposite effect in colorectal cancer, where it promotes tumor growth, researchers at Vanderbilt University Medical Center have reported. -
June 29, 2023
Study identifies key regulator of melanoma development
Vanderbilt investigators have revealed the mechanisms by which the chemokine receptor CXCR2, is associated with melanoma tumor formation and growth — a discovery that supports the continued development of drugs that inhibit the receptor’s activity.